Key Competitors - Cardiac Biomarkers Industry

 

Over the coming years, the global market for cardiac biomarkers is anticipated to rise as more people are being diagnosed with cardiovascular illness. For example, the American College of Cardiology Foundation estimates that around 1.05 million Americans had coronary illnesses in 2019. In addition, the Centres for Disease Control and Prevention (CDC) report 2020 states that every year, about 805,000 Americans get a heart attack.

The market for Cardiac biomarkers is anticipated to reach an estimated US$ 8,099.9 Mn in 2021 and grow at a CAGR of 10.2% from 2021 to 2028.

Prominent Companies in the Cardiac Biomarkers Industry:

1. Abbott produces and sells branded generic pharmaceuticals, adult and paediatric nutritional items, diagnostic tools, and testing kits. Pacemakers, implanted cardioverter defibrillators, neuromodulation tools, coronary stents, catheters, baby formula, adult dietary liquids, molecular diagnostic platforms, immunoassays, and point-of-care diagnostic tools are among the products. Built in 1888. American headquarters in North Chicago. Recent Acquisitions: Cephea Valve Technologies (Jan 2019), JETi (Sep 2021), Cardiovascular Systems (Feb 2023).

Abbott Laboratories:

2.  Tasmar's rights to production, marketing, and distribution in the United States and a few other non-European Union areas. Parkinson's illness is managed with the medication tasmar. United States headquarters. For $449 million, Roche buys the biotech company Inflazome.

F. Hoffmann-La Roche AG:

3. Thermo Fisher Scientific sells reagents for life sciences, laboratory supplies, and equipment for diagnostics. Founded 1956. United States headquarters.

Thermo Fisher Scientific Inc.:

4.  With its headquarters in Hercules, California, Bio-Rad Laboratories creates, produces, and sells goods and services for the clinical diagnostics and life sciences industries. Bio-Rad produces, markets, and maintains test systems and specialised quality controls for clinical laboratories in the diagnostics sector (53% of revenue). Built in 1952. United States headquarters. Scope Fluidics, S.A., a Warsaw, Poland-based developer of innovative technology solutions for the medical diagnostic and healthcare markets, has agreed to sell all of Curiosity Diagnostics, Sp. Z. o. o.'s outstanding shares to Bio-Rad Laboratories for a total consideration of up to $170 million, consisting of roughly $100 million in cash, up to $70 million in stock, and up to $70 million in cash.

Bio-Rad Laboratories, Inc.:

5. Established in 1969. Admin centre in the U.S. The founders of Danaher converted a real estate company into a manufacturing business with an industrial focus in 1984. Danaher today largely concentrates on producing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. This has been achieved through a succession of mergers, acquisitions, and divestitures. The business revealed plans to sell its environmental and applied solutions division in 2023, allowing it to only concentrate on the life sciences and diagnostics. 

Danaher Corporation:

6. service provider for immunodiagnostics. The company's immunodiagnostics is a diagnostic methodology that uses an antigen-antibody response as their primary way of detection of the existence of the tumour linked with that antigen, enabling medical professionals to quickly diagnose any tumour present in the body. Established in 2015. German headquarters are at Erlangen.

Siemens Healthiness,:

7. A wide range of in vitro diagnostics are created, developed, and manufactured by BioMerieux with the purpose of identifying contamination and disease-causing bacteria. Molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (approximately 17%) make up the company's four business divisions. 49% of the company's sales comes from the Americas, followed by 33% from Europe, the Middle East, and Africa, and 18% from Asia-Pacific. The headquarters of BioMerieux are in Marcy-l'Etoile, France. Established in 1963. French headquarters.

BioMérieux SA:

 

*Definition:

This test measures the levels of cardiac biomarkers in your blood. These markers include enzymes, hormones, and proteins.